Related Experiment Video
Updated: Jan 16, 2026

A Modified Simple Method for Induction of Myocardial Infarction in Mice
Published on: December 3, 2021
Myocardial infarction induces endothelial dysfunction with independence of cardiovascular risk factors
Francisco Rafael Jimenez-Trinidad1, Núria Solanes1, Marta Arrieta1
1Cardiology Department, Institut Clinic Cardiovascular (ICCV), Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
Insights
Myocardial infarction (MI) causes lasting endothelial colony-forming cell (ECFC) dysfunction, independent of cardiovascular risk factors. Targeting the MSK2/MKK3/p53 pathway may restore endothelial function and improve angiogenesis post-MI.
Area of Science:
- Cardiovascular Biology
- Endothelial Cell Biology
- Ischemic Heart Disease Research
Background:
- Endothelial dysfunction and impaired angiogenesis are key features of ischemic heart disease.
- Myocardial infarction (MI) significantly impacts cardiovascular outcomes.
- The direct effect of MI on endothelial function, independent of cardiovascular risk factors (CVRFs), is not fully understood.
Purpose of the Study:
- To investigate the direct impact of MI on endothelial function.
- To utilize human and porcine endothelial colony-forming cells (ECFCs) as a model to assess MI-induced endothelial dysfunction.
- To determine if MI triggers endothelial dysfunction independently of CVRFs.
Main Methods:
- Isolated human ECFCs (hECFCs) from healthy volunteers, patients immediately after MI (AMI), and 6 months post-MI (CMI).
- Established a porcine model of MI, isolating porcine ECFCs (pECFCs) before and 1 month after MI (CMI).
- Assessed ECFC colony formation, morphology, senescence, oxidative stress, proliferation, migration, and the MSK2/MKK3/p53 signaling pathway.
Main Results:
- CMI-hECFCs and CMI-pECFCs showed delayed colony formation; AMI-hECFCs did not.
- AMI-hECFCs and CMI-hECFCs exhibited morphological changes; CMI-pECFCs showed shape changes.
- Senescence increased in AMI-hECFCs and CMI-hECFCs; oxidative stress elevated only in CMI-hECFCs.
- Angiogenic and proliferative capacities were reduced in all MI-affected ECFCs; migration impaired in CMI-hECFCs and CMI-pECFCs.
- Overactivation of the MSK2/MKK3/p53 axis was observed in dysfunctional ECFCs.
Conclusions:
- Myocardial infarction induces persistent ECFC dysfunction, independent of CVRFs.
- The MSK2/MKK3/p53 signaling pathway is implicated in MI-induced ECFC dysfunction.
- Inhibiting the MSK2/MKK3/p53 pathway offers a potential therapeutic strategy for improving endothelial function and angiogenesis post-MI.
Aims:
Endothelial dysfunction and impaired angiogenesis are hallmarks of ischemic heart disease and critical determinants of adverse cardiovascular outcomes after myocardial infarction (MI). While conventional cardiovascular risk factors (CVRFs) are known contributors, the specific role of MI itself triggering endothelial dysfunction remains unclear. This study aims to assess the direct impact of MI on endothelial function, independent of cardiovascular risk factors, using human and porcine endothelial colony-forming cells (ECFCs) as a surrogate cellular model.
Methods And Results:
Human ECFCs (hECFCs) were isolated from the peripheral blood of healthy volunteers (Control-hECFCs, n = 6), patients immediately after MI (AMI-hECFCs, n = 6), and patients 6 months after MI (CMI-hECFCs, n = 6). To evaluate the direct effect of MI independently of CVRFs, a porcine model was used: healthy pigs (n = 6) underwent 90 min of myocardial ischemia by coronary balloon occlusion followed by reperfusion. Porcine ECFCs (pECFCs) were isolated before MI (Control-pECFCs) and one month after MI (CMI-pECFCs, n = 6). In vitro, CMI-hECFCs and CMI-pECFCs had delayed colony formation, whereas AMI-hECFCs did not. Morphological alterations were observed in AMI-hECFCs and CMI-hECFCs (area and shape), while only shape changes were found in CMI-pECFCs. Senescence was increased in AMI-hECFCs and CMI-hECFCs, but not in CMI-pECFCs. Elevated oxidative stress was only detected in CMI-hECFCs. Functional angiogenic and proliferative capacities were reduced in AMI-hECFCs, CMI-hECFCs and CMI-pECFCs; however, only CMI-hECFCs and CMI-pECFCs displayed impaired migration. Molecular analysis showed overactivation of the MSK2/MKK3/p53 signalling axis in dysfunctional ECFCs, while synergistic inhibition of the axis partially restored ECFC function.
Conclusions:
MI induces sustained ECFC dysfunction independently of cardiovascular risk factors. Targeting the MSK2/MKK3/p53 pathway may be a promising therapeutic strategy to restore endothelial function and improve angiogenesis after MI.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Pathophysiology of Cardiac Performance

